News & Updates
Filter by Specialty:
Novel SGLT2 inhibitor cuts HbA1c, plasma glucose, body weight in type 2 diabetes
31 Oct 2021
Ertugliflozin, a novel sodium-glucose cotransporter inhibitor, helps reduce glycated haemoglobin (HbA1c), body weight, and fasting plasma glucose (FPG) in patients with type 2 diabetes, reports a recent meta-analysis.
Novel SGLT2 inhibitor cuts HbA1c, plasma glucose, body weight in type 2 diabetes
31 Oct 2021
Air pollution compromises exercise responses more in healthy people than ex-smokers
31 Oct 2021
Exposure to traffic-related air pollution takes a toll on exercise responses among healthy people but not former smokers with or without chronic obstructive pulmonary disorder (COPD), a study has found.
Air pollution compromises exercise responses more in healthy people than ex-smokers
31 Oct 2021
Patients presenting with advanced-stage pancreatic cancer reveal cracks in imaging-based surveillance
31 Oct 2021
High-risk individuals who develop neoplastic progression to pancreatic cancer or high-grade dysplasia can present at an advanced stage despite showing no lesions during prior imaging surveillance evaluations, a new study has found.
